The global newborn screening market is expected to reach USD 1.43 billion by 2022, according to a new report by Grand View Research Inc. Increasing occurrence of congenital disorders that lead to mental retardation or dysfunctioning body organs and the availability of advanced screening technologies are expected to drive market growth over the forecast period. Furthermore, the market is expected to witness a boost in demand owing to, the presence of Federal Bodies involved in organizing awareness and quality assurance programs to imbibe faith and decrease the number of deaths caused due to negligence & non-screening. For instance, in 2011, the Ministry of Health, Japan recommended the use of mass spectrometry in newborn screening and by 2014, the entire nation started utilizing it for 19 critical conditions. Access Full Research Report by Grand View Research: http://www.grandviewresearch.com/industry-analysis/newborn-screening-market Further key findings from the study suggest:
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it Grand View Research has segmented the global newborn screening market on the basis of product, technology, test type and region: Product Outlook (Revenue, USD Million, 2012 - 2022)
Access press release by Grand View Research: http://www.grandviewresearch.com/press-release/global-newborn-screening-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. For more information: http://www.grandviewresearch.com
0 Comments
Leave a Reply. |